Ansa Biotechnologiesincis A Synthetic Biology Company Based In Emeryvillecaliforniafounded In 2018The Company Specializes In Enzymatic Dna Synthesisaiming To Improve Dna Manufacturing By Overcoming The Limitations Of Traditional Chemical Synthesis Methodsansa Has Successfully Raised $82 7 Million In Fundingincluding A Significant $68 Million In Its Previous Round Ansa Develops Next Generation Dna Synthesis Technology That Allows For Fastermore Accurateand Environmentally Friendly Production Of Synthetic Dnathey Offer Custom Dna Synthesis Servicesdelivering Sequences Up To 600 Base Pairswith Plans To Expand To Larger Constructstheir Early Access Program Provides Priority Access To Synthesis Services And Consultations For Complex Projectsansa S Technology Is Particularly Adept At Handling Complex Dna Sequencesincluding Those With High Gc Content And Secondary Structuresmaking It Valuable For Various Industries Such As Healthcarebiological Researchfood And Agricultureand Industrial Biotechnology
